# Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer

> **NCT00193427** · PHASE2 · COMPLETED · sponsor: **SCRI Development Innovations, LLC** · enrollment: 75 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Gemcitabine
- **DRUG:** Carboplatin
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT00193427
- **Lead sponsor:** SCRI Development Innovations, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00193427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00193427, "Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00193427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*